Molecular Imaging of Interstitial Alterations in Remodeling Myocardium After Myocardial Infarction  by van den Borne, Susanne W.M. et al.
H
c
F
†
t
N
L
t
c
T
s
A
g
N
e
a
Journal of the American College of Cardiology Vol. 52, No. 24, 2008
© 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00
PPRE-CLINICAL RESEARCH
Molecular Imaging of Interstitial Alterations
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Objectives The purpose of this study was to evaluate interstitial alterations in myocardial remodeling using a radiolabeled
Cy5.5-RGD imaging peptide (CRIP) that targets myofibroblasts.
Background Collagen deposition and interstitial fibrosis contribute to cardiac remodeling and heart failure after myocardial infarc-
tion (MI). Evaluation of myofibroblastic proliferation should provide indirect evidence of the extent of fibrosis.
Methods Of 46 Swiss-Webster mice, MI was induced in 41 by coronary artery occlusion, and 5 were unmanipulated.
Of the 41 mice, 6, 6, and 5 received intravenous technitium-99m labeled CRIP for micro–single-photon
emission computed tomography imaging 2, 4, and 12 weeks after MI, respectively; 8 received captopril or
captopril with losartan up to 4 weeks after MI. Scrambled CRIP was used 4 weeks after MI in 6 mice; the
remaining 10 of 46 mice received unradiolabeled CRIP for histologic characterization.
Results Maximum CRIP uptake was observed in the infarct area; quantitative uptake (percent injected dose/g) was highest at
2 weeks (2.75  0.46%), followed by 4 (2.26  0.09%) and 12 (1.74  0.24%) weeks compared with that in unma-
nipulated mice (0.59  0.19%). Uptake was higher at 12 weeks in the remote areas. CRIP uptake was histologically
traced to myofibroblasts. Captopril alone (1.78 0.31%) and with losartan (1.13 0.28%) significantly reduced tracer
uptake; scrambled CRIP uptake in infarct area (0.74  0.17%) was similar to CRIP uptake in normal myocardium.
Conclusions Radiolabeled CRIP allows for noninvasive visualization of interstitial alterations during cardiac remodeling, and
is responsive to antiangiotensin treatment. If proven clinically feasible, such a strategy would help identify
post-MI patients likely to develop heart failure. (J Am Coll Cardiol 2008;52:2017–28) © 2008 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.07.067a
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ardiovascular health problems worldwide. In the U.S.
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ccepted July 31, 2008.lone, approximately 5 million people suffer from manifest
F and more than 500,000 new cases are diagnosed every
ear (1). The syndrome of HF post-myocardial infarction
MI) is characterized by a relentless course of myocardial
emodeling and functional deterioration (2–4), which con-
See page 2029
inues to occur even after the initial causative injury has
bated (5,6). In addition to the replacement fibrosis in the
egion of MI, interstitial fibrosis in the noninfarcted myo-
ardium significantly contributes to the adverse remodeling
nd HF (7). In fact, presence of fibrosis remote from the
nfarct zone accounts for two-thirds of the fibrous tissue in
he cardiomyopathic heart (7–10). The magnitude of myo-
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Imaging Interstitial Alterations After MI December 9, 2008:2017–28cardial fibrosis is correlated to the
extent of ventricular dysfunction
(11). It is conceivable that an abil-
ity to noninvasively detect the pro-
cess of myocardial fibrosis would
allow assessment of the likelihood
of evolution of HF after MI.
Collagen production and fi-
brosis in the myocardium are as-
sociated with myofibroblastic
proliferation (5). Myofibroblasts
demonstrate up-regulation of an-
giotensin receptors and integrin
moieties, which, in turn, may
promote collagen genes and re-
duce metalloproteinase genes
(12). Such effects of integrin up-
regulation are prevented by abro-
gation of autocrine transforming
growth factor- signaling (12).
The RGD peptide (containing
the arginine-glycine-aspartate
otif) that binds to integrins such as v3 has been used to
dentify neovascularization in post-infarct animal models
13). Since integrin v3 is associated with the supermature
ocal adhesions on the cell membrane of myofibroblasts, we
ypothesized that appropriately labeled RGD probes should
dentify myofibroblasts in post-infarct myocardium (14). In
ddition, scrutiny of the pro-collagen I sequence revealed
GD binding domains, such as DDX, and could also
onstitute a target for RGD-based imaging. Therefore,
ptake of RGD probe should indirectly represent the rate of
brogenesis or collagen deposition.
In the present study, we used Cy5.5-RGD imaging
eptide (CRIP) labeled with technetium (Tc)-99m, for
easibility of imaging the process of active myocardial
brosis in a murine model of post-MI ventricular dysfunc-
ion. The noninvasive imaging ability of the radiolabeled
robe was compared with echocardiographic parameters of
eft ventricular (LV) geometric changes and pathologic
haracterization of interstitial alterations. The fluorescent
oiety of the targeting peptide allowed better histologic
haracterization of the probe localization. An antibody
gainst the fluorescent moiety of CRIP was used to immuno-
lectron microscopically trace the localization of CRIP. In
ddition, in vitro experiments were performed for charac-
erization of the CRIP binding to mature and pro-collagen.
lassification of Animals Used in the Study
Table 1 Classification of Animals Used in the Study
Probe Label Control, n 2 Weeks, n
Cy5.5-RGD Tc 5 6
Cy5.5-RGD — — 10
Cy5.5 scrambled Tc — —
Abbreviations
and Acronyms
ASMA  alpha smooth
muscle actin
CRIP  Cy5.5-RGD imaging
peptide
CT  computed
tomography
HF  heart failure
LV  left
ventricle/ventricular
MI  myocardial infarction
PBS  phosphate-buffered
saline
RGD 
arginine-glycine-aspartate
SPECT  single-photon
emission computed
tomography
Tc  technetiumGD  arginine-glycine-aspartate; Tc  technetium.ethods
xperimental myocardial infarction in mice. The exper-
mental protocol was approved by the Institution Animal
are and Use Committee of the University of California,
rvine, School of Medicine. In 41 adult Swiss Webster male
ice (age: 4 months; body weight: 50 g), MI was induced
nder pentobarbital (75 mg/kg) and isoflurane gas anesthe-
ia (2.0% to 3.0%) using a stereomicroscope (Leica MZ FL
II, Leica, Switzerland). For this purpose, animals were
laced on a heating pad in the supine position, endotracheal
ntubation was performed under direct laryngoscopy, and
echanical ventilation was maintained with a small animal
espirator (Harvard Apparatus, Holliston, Massachusetts)
tidal volume  1.0 ml, rate  120 breaths/min). After
horacotomy, the lateral branch of the left coronary artery
as ligated with a 6.0-silk suture 3 to 4 mm below the tip
f the left atrium. Successful ligation was verified by visual
nspection of the LV apex for myocardial blanching, indicating
nterruption in coronary flow. The chest cavity was closed in
ayers with 6.0-silk, and the skin closed with 4.0-silk sutures.
nimals were gradually weaned from the respirator.
For evaluation of serial changes in collagen synthesis by
adiolabeled CRIP imaging, animals were divided into
roups at 2 weeks (n  6), 4 weeks (n  6), and 12 weeks
n  5) after infarction (Table 1). Two groups of 4 animals
ach were treated with either captopril (60 mg/kg/day)
lone or in combination with losartan (captopril 30 mg/kg/
ay, losartan 10 mg/kg/day) dissolved in the drinking water,
o evaluate if molecular imaging with CRIP would allow
etermination of efficacy of therapeutic intervention. Five
nmanipulated control mice were subjected to CRIP imag-
ng for comparison with the infarcted mice after a 4-week
ait. In addition, 6 animals, 4 weeks after MI, were imaged
ith Tc-labeled scrambled peptide (scrambled CRIP) to
nsure the specificity of CRIP. In the remaining 10 mice,
onradiolabeled CRIP was used for pathologic character-
zation of the target using fluorescence microscopy and
mmunoelectron microscopy.
chocardiography. All animals were subjected to extensive
chocardiographic studies for the assessment of myocardial
nfarct size, LV cavity dimensions, and ventricular function.
Echocardiographic examination was performed under 2%
soflurane anesthesia for the assessment of infarct size, LV
avitary dimensions, and ventricular function before nuclear
maging. Echocardiograms were recorded with a commer-
ially available ultrasound system (Sequoia, Siemens,
eeks, n 12 Weeks, n
4 Weeks, n
Captopril Captopril  Losartan
6 5 4 4
— — — —
6 — — —4 W
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December 9, 2008:2017–28 Imaging Interstitial Alterations After MIountain View, California) using a 14-MHz linear probe
15L8, Siemens). An advanced high frame rate imaging
echnique, acoustic capture (Paragon, Siemens), was
dopted for image acquisition allowing temporal resolution
f 8 to 10 ms (frame rate, 100 to 120/s). B-mode images of
V parasternal long- and short-axis views at base, mid, and
pical LV levels were digitally stored as movie loops in 2 to
cardiac cycle lengths. Still images of LV M-mode as well
s pulsed-wave Doppler spectrum of mitral valve inflow and
ortic valve forward flow were acquired at a sweep of 100
m/s. Infarct and LV area were measured by tracing
ndocardial borders on long-axis images, and infarct-to-LV
atio was calculated. LV wall thicknesses and cavity dimen-
ions were measured on LV M-mode spectrum as recom-
ended by the American Society of Echocardiography
uidelines (15), followed by calculation of percent fractional
hortening and ejection fraction.
RIP and scrambled CRIP: structure and radiolabeling.
RIP and scrambled CRIP were the kind gift of GE Health-
are, AS, Oslo, Norway. CRIP (AH110863) (Fig.1) is a
.5-kD peptide conjugated to both a fluorescent cyanine dye
y5.5 and the chelating agent cPN216; the latter is linked for
adiolabeling of the peptide with 99mTc. The peptide com-
rises 10 amino acids, contains an RGD-motif, and has a
icyclic structure formed by a disulfide and a thioether
ridge. The dye moiety and the chelating agent are conju-
ated to the peptide via the side-chain of lysine residue at
Figure 1 The Structure of CRIP
CRIP is a 2.5-kD, 10-amino acid peptide, which contains an arginine-glycine-aspart
thioether bridge. It is conjugated to both a fluorescent cyanine dye (Cy5.5) and the
the chelating agent are conjugated through the lysine side-chain at the N- and C-te
acids in CRIP was mixed so the sequence did not express the RGD-motif; the dyehe N- and C-terminal ends, respectively. A scrambled
ersion of CRIP (AH112298) was also prepared, in which
he order of the amino acids in CRIP was altered so that the
equence did not express an RGD-motif. The dye and the
helating agent were conjugated at the same positions.
For radiolabeling, 50 g of tracer was dissolved in 50 l
f MeOH and then added to a freeze-dried kit. One
illiliter of 99mTcO4
 was added to the compound and left
t room temperature for 20 to 30 min. Radiolabeling was
onfirmed by instant thin-layer chromatography with radio-
urity of more than 90%. For nuclear imaging, 170  18
Bq (4.6  0.4 mCi) of Tc-CRIP was injected through
he tail vein and imaging was performed after 3.5 h.
icro–single-photon emission computed tomography
SPECT) imaging with Tc-CRIP and micro-computed
omography (CT). Radionuclide imaging was performed
sing a dual-head micro-SPECT gamma camera with
icro-CT (X-SPECT, Gamma Medica, Inc., Northridge,
alifornia) under isoflurane anesthesia. In vivo micro-
PECT images of the heart were acquired in a 64  64
caffold, 32 steps at 120 s/step on a 140-keV photopeak of
9mTc with a 15% window using a low-energy, high-
esolution, pinhole collimator. After SPECT acquisition,
icro-CT images were acquired without moving the mice.
he micro-CT used an X-ray tube operating at 50 kVp and
.6 mA, and images were acquired for 0.5 s/view for 256
iews in 360° rotation. The micro-SPECT images were
GD)-motif and has a bicyclic structure formed by a disulfide bridge and a
ting agent cPN216 for radiolabeling with technetium-99m; the dye moiety and
ends, respectively. For preparation of scrambled CRIP, the order of the amino
e chelating agent were conjugated similarly (not shown).ate (R
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Imaging Interstitial Alterations After MI December 9, 2008:2017–28onverted to 256 256 scaffold and micro-CT studies were
used, allowing simultaneous scintigraphic and anatomic
nformation in all tomographic scans in 3 different axes.
fter in vivo imaging, animals were sacrificed with an
verdose of pentobarbital (150 mg/kg). Hearts were care-
ully explanted, and planar images of ex vivo heart were
cquired for 15 min in a 128  128 matrix using a
ow-energy, high-resolution, pinhole collimator. Thereafter,
earts were cut into 3 bread-loaf slices (infarct, peri-infarct,
nd remote regions), using a mouse heart matrix (Zivic
aboratories, Inc., Pittsburgh, Pennsylvania). The quanti-
ative radiotracer uptake was determined by a gamma
cintillation counter (1480 Wizard 3, Wallac Co.,
altham, Massachusetts). Biodistribution studies for the
ung, liver, spleen, and kidney uptake were also undertaken.
istopathologic characterization of myocardial speci-
ens. After the nuclear imaging studies, the apical (pre-
ominantly containing infarct tissue), mid myocardium
peri-infarct), and basal (predominantly containing nonin-
arcted remote tissue) myocardial slices were washed in
hosphate-buffered saline (PBS), fixed overnight with 4%
araformaldehyde in PBS (pH 7.4 at 4°C), and stored in
BS with 0.02% sodium azide at 4°C until used. The
pecimens were further processed by dehydration in a
raded series of ethanol for paraffin-embedding. The blocks
ere cut in 5-m sections, transferred to Vectabond (Vector
aboratories, Burlingame, California) reagent-treated slides
Vector SP-1800, Vector Laboratories), dried overnight,
nd stored until ready for use.
Masson’s trichrome staining was used to determine in-
arct size. After deparaffinization and rehydration, sections
ere placed in working Weigert’s iron hematoxylin for 10
in and tepid water rinsed for 10 min. Tissue sections were
hen incubated in Biebrich scarlet-acid fuchsin solution for
min, differenced in phosphotungstic-phosphomolybdic
cid for 5 min, and stained in aniline blue for 8 min. After
insing with 1% gallic acetic acid, sections were dehydrated
nd mounted in permanent mount medium.
Sirius red staining eliminates cytoplasmic staining, re-
ealing thin septa and collagen fibers clearly, and enabling
uantitative morphometric measurements. Sections were
reated in 0.2% aqueous phosphomolybdic acid for 5 min
nd subsequently incubated for 60 min with 0.1% sirius red
3BA (C.I. 35780, Polysciences, Northhampton, United
ingdom) in saturated picric acid and washed for 2 min
ith 0.01 N HCl. Sections were rinsed in 70% alcohol for
0 s, then dehydrated and mounted with a cover-slip, and
he amount of collagen was quantified (16). The quality of
ollagen fibers was further investigated by sirius red polar-
zation microscopy, allowing semiquantification of the ma-
ure, thick, tightly packed orange/red fibers and the newly
ormed, thin, loosely assembled fibers as yellow/green (17–20).
Alpha smooth muscle actin (ASMA) was used to deter-
ine myofibroblasts in the infarct area. After deparaffiniza-
ion, rehydration, and blocking of endogenous peroxidase,
ections were incubated for 2 h at room temperature using Cnti-ASMA (ASMA monoclonal antibody, Sigma, St.
ouis, Missouri, dilution 1:2,000). After washing in PBS,
ections were incubated with secondary antibody (rabbit
ntimouse horseradish peroxidase, 1:500, DAKO, Carpin-
eria, California) for 1 h at room temperature. Sections were
riefly counterstained with hematoxylin.
luorescence microscopy. For localization of the target
ites for CRIP, nonradiolabeled probe was injected intrave-
ously in animals with 2-week-old MI. After 3.5 h, mice
ere sacrificed and hearts were excised. Frozen sections of 5
m were cut and rehydrated in PBS. Sections were incu-
ated for 2 h at room temperature using anti-ASMA
ntibody (1:2,000, Sigma). After washing in PBS, sections
ere incubated with secondary antibody for 1 h at room
emperature (donkey antimouse IgG FITC, Jackson Immu-
oResearch Europe, Newmarket, Suffolk, United King-
om). Sections were examined using a Nikon Eclipse E-800
icroscope (Nikon Instruments Europe B. V., Amstelveen,
he Netherlands).
n vitro studies for CRIP binding. Modified enzyme-
inked immunoadsorbent assays were developed for defining
he interaction of CRIP and collagen I and III (Sigma
ldrich, St. Louis, Missouri). In addition, a pro-collagen I
eptide was custom constructed containing a DDX se-
uence (H2N-GPP-GKN-GDD-GEA-GKP-GR-
OOH). This sequence is common for mouse and human
ro-collagen I. The analysis was conducted using a Biacore
000 system (Biacore, GE Healthcare, Uppsala, Sweden)
hat enabled detection of noncovalent interactions between
RIP and pro-collagen I peptide in real time, applying the
hysical principle of surface plasmon resonance. The analysis
nvolved immobilization of synthetic peptide sequence on
ensor chips CM5, followed by assessment of soluble CRIP or
crambled CRIP to the immobilized ligand. The change in
efractive index at the chip surface layer, as the soluble
omponents associated with the ligand and subsequently dis-
ociated, was expressed as resonance units. To compensate for
onspecific background binding, an unmodified control sur-
ace was used. The change in resonance units at this surface
as subtracted from the change in resonance units at the ligand
urface.
mmunoelectron microscopy. Immunoelectron micros-
opy was performed according to previously described
ethods (21). In short, hearts were perfused with 0.2%
lutaraldehyde in 2% paraformaldehyde and 0.1 mol/l
hosphate buffer, pH 7.4. Hearts were excised and stored
or 60 min in the previously mentioned solution before
torage in 1% paraformaldehyde and 0.1 mol/l phosphate
uffer, pH 7.4 at 4°C for at least 24 h. Tissue samples were
tored in 2.3 mol/l sucrose in 0.1 mol/l phosphate buffer,
nd sections were cut and placed on a grid in methyl
ellulose/2.3 mol/l sucrose solution (1:1). Anticyanine anti-
ody was used (Acris Antibodies, Hiddenhausen, Germany)
o ultrastructurally trace CRIP localization. After protein A
old labeling, sections were examined using a Philips
M100 microscope (Eindhoven, the Netherlands).
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ance of differences in quantitative scintigraphic data, echo-
ardiographic parameters, and histopathologic observations,
-way analysis of variance was performed followed by
ost-hoc Bonferroni test for multiple comparisons. Corre-
ations were determined using linear regression analysis.
ue to the small number of mice in each group, the
ssumptions of the 1-way analysis of variance and linear
egression models should be regarded as exploratory rather
han definitive. The p values of 0.05 were considered
tatistically significant.
esults
RIP: target affinity and localization characteristics. Probe
ocalization characteristics were determined by fluorescence
icroscopy of myocardial tissue sections of hearts explanted
weeks after MI from animals injected with (nonradiola-
eled) CRIP (Fig. 2). Uptake was observed predominantly
n the myocardial infarct zone. Colocalization of ASMA in
he same cells as CRIP-positive cells by fluorescence mi-
roscopy suggested the probe specificity for myofibroblasts.
imilarly, immunoelectron microscopic examination was
erformed wherein intravenously administered CRIP in
-week-old infarcts was localized by immunogold-labeled
nticyanine antibody. Uptake was confirmed in the myofi-
roblasts, which were ultrastructurally identified by the
resence of large amounts of rough endoplasmic reticulum.
small amount of internalized CRIP was seen within the
yofibroblasts. No uptake of the probe was observed in the
xternalized collagen fibers. In vitro binding assays revealed
RIP uptake by activated v3/5 with an affinity of 1-3nM,
ut not by typical collagen receptors such as 11 or 51 or
latelet receptor II3. Also, CRIP did not bind to mature
ollagen type I or III fibers. However, a specific noncovalent
nteraction of CRIP was observed with a custom-made
DX-sequence containing pro-collagen I peptide (Fig. 2).
adionuclide imaging with Tc-CRIP. The infarct size in
ll untreated animals was similar (Table 2). The LV cavity
imensions (both end-systolic and diastolic) were greater at
, 4, and 12 weeks post-MI, and the percent fractional
hortening and ejection fraction decreased post-MI com-
ared with those in normal control animals. In vivo micro-
PECT imaging demonstrated Tc-CRIP uptake in the
nfarct area (Fig. 3). The use of micro-CT identified precise
ocalization of the radioactivity in the cardiac region and
llowed differentiation of the uptake in apical myocardium
rom radiotracer sequestration in the liver. Ex vivo planar
mages of the explanted heart specimens confirmed the
esults of in vivo imaging and demonstrated maximum
ptake in infarct and border zones. Minimal increase in
ptake was seen in the remote area (Fig. 4). In contrast to
RIP, scrambled CRIP did not show uptake in the in-
arcted myocardium, showing that CRIP uptake is RGD-
ependent and -specific. Similarly, no Tc-CRIP uptake was
een in the unmanipulated hearts. rUptake in the infarcted region was maximal in the
-week-old MI. There was statistically significant reduction
n uptake in 4- and 12-week-old infarcts (Fig. 4). Quanti-
ative Tc-CRIP uptake in the myocardial tissue specimens
as calculated and represented as percent injected dose/g
%ID/g) of tissue. It can be presumed that the quantitative
ptake represents the extent of the process of myocardial
brosis. As observed in the in vivo and ex vivo images, the
aximum radiotracer uptake was observed in the infarcted
yocardium (%ID/g: 2.75  0.46%) at 2 weeks, which was
-fold higher than the control myocardial specimens (0.59
0.19%; p  0.0001) (Fig. 4B). This uptake was signifi-
antly higher compared with specimens from 4 (2.26 
.17%; p  0.0038) and 12 (1.74  0.24%; p  0.0001)
eeks after MI. The CRIP uptake in the remote myocar-
ium was higher than that in the control myocardial
pecimens, and it increased significantly by 12 weeks (1.04 
.13%), as compared with uptake in control myocardial
pecimens (0.68  0.16%; p  0.001). The uptake in the
nfarct area had no correlation with MI size determined
ither by akinetic echo segments or Masson trichrome
taining (r  0.17, 0.12 respectively; p  NS). The
ontarget organ distribution of Tc-CRIP demonstrated the
idney to be the major organ of radiation burden (and
xcretion) (Online Appendix). The tracer clearance was fast,
nd only 8% of the tracer could be recovered in circulation
t 2 h as compared with 5 min after administration; CRIP
1/2 was calculated as 28 min.
Two additional groups of 4 animals each were treated
ith either captopril alone or in combination with losartan.
pon ultrasound examination, the neurohumoral antago-
ists prevented ventricular dilation and preserved ventricular
unction (Table 2). The CRIP uptake at 4 weeks after MI
as significantly reduced after captopril (1.78  0.31%;
 0.0004) or captopril  losartan (1.13  0.28%; p 
.0001) treatment compared with uptake in untreated
nimals (Fig. 5).
istopathologic assessment. The histologic sections
emonstrated large infarcts involving the anterior LV wall
Fig. 6); infarct size was similar in all animals. During the 3
onths following infarction, the LV wall demonstrated
ignificant thinning and the extent of inflammation gradu-
lly subsided. Myofibroblasts, expressing ASMA, were
resent at 2 weeks post-MI in the infarct area and decreased
ver time. Replacement and interstitial collagen was ana-
yzed by picrosirius red polarization microscopy of myocar-
ial specimens (Fig. 7) obtained from infarct and remote
egions. Although the total collagen content in the infarct
egion remained similar over time, the thin, newly formed
yellow/green) collagen fibers reduced and correlated with
he radiotracer uptake (r2  0.34; p  0.05) (Figs. 7A, 7C,
nd 7E). In the remote region, overall collagen deposition
as markedly lower compared with that in the infarct region
Figs. 7A and 7B). However, both collagen content and
yellow/green) thin collagen fibers increased in the remote
egion over time (Fig. 7D). There was a direct correlation
2022 van den Borne et al. JACC Vol. 52, No. 24, 2008
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Figure 2 Characterization of Target Binding of CRIP
Probe targeting was evaluated 3.5 h after intravenous administration of Cy5.5-RGD imaging peptide (CRIP) in 2-week post-myocardial infarction (MI) animals. Localization
of the Cy5.5 fluorescence (red) was clearly observed in the infarct and peri-infarct zones in vivo (A, arrows). A 30- whole mouse slice demonstrates myocardial uptake
of the probe (B, square); intense uptake is seen in the kidney, which serves as the route of excretion. (C) Magnification of the area enclosed by the box in panel B
demonstrates fluorescent probe localization in the subendocardium. (D to G) For further characterization of the probe targets, we correlated the uptake of intravenously
administered CRIP in 2 week post-MI animals (red, D) with concurrent staining of the sections by anti-alpha smooth muscle actin (ASMA) antibody (green, E), colocaliza-
tion is shown by overlay (F). The localization of CRIP was observed in spindle-shaped myofibroblasts in the infarct area. CRIP and ASMA colocalization is seen in trans-
versely sectioned myofibroblasts in (G). For immunoelectron microscopy, intravenously administered CRIP was traced by gold labeled anticyanine antibody (black
immunogold particles, 10 nm). CRIP clearly localized with myofibroblasts (H), containing a characteristic abundance of rough endoplasmic reticulum (I). No uptake was
seen in mature collagen fibers outside of myofibroblasts (J); (K) sensograms (Biacore 3000 instrument) obtained with CRIP and scrambled CRIP exposure to a surface
with an immobilized DDX peptide sequence H2N-GPP-GKN-GDD-GEA-GKP-GR-COOH, aa221-240 from pro-collagen I. In addition, arginine-glycine-aspartate (RGD) imaging
peptide without Cy5.5 dye was used in the experiment (RIP). The higher resonance unit values for CRIP than RIP are due to the higher molecular weight of CRIP.
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r2  0.45; p  0.001) (Fig. 7F). The direct correlation of
RIP uptake with ASMA-positive myofibroblasts and thin
ollagen fibers suggests that collagen production is de-
reased in the infarct zone over time.
iscussion
he present study demonstrates the feasibility of noninva-
ive assessment of interstitial alterations in post-infarction
entricular myocardium by Tc-99m labeled CRIP. The lack
f binding of scrambled CRIP (which carries a deranged
GD-motif) confirmed that the CRIP binding is RGD-
ependent and specific. Fluorescence and immunoelectron
icroscopy confirmed the binding of CRIP to the myofi-
roblasts. The CRIP uptake paralleled newly formed, thin,
ellow/green collagen fiber production, suggesting that the
RIP uptake should indirectly represent the rate of collagen
eposition. CRIP did not bind to the mature collagen fibers.
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Figure 3 In Vivo Micro-CT, Micro-SPECT, and Fusion Images in
in Unmanipulated Control and 4-Week Post-MI Animal
No uptake of technetium-labeled Cy5.5-RGD imaging peptide (Tc-CRIP) was observ
is seen in the infarcted mouse (bottom row). The cardiac localization is confirmed
single-photon emission computed tomography.
chocardiographic Parameters of LV Remodeling and Function
Table 2 Echocardiographic Parameters of LV Remodeling and F
Parameter Normal Control 2 Weeks 4 W
n 5 6
HR (beats/min) 386 55 476 43† 406
MI (%) 0 47 14† 48
LVDd (cm) 0.46 0.03 0.53 0.03† 0.49
LVDs (cm) 0.29 0.03 0.48 0.03† 0.44
FS (%) 38 4 11 4† 11
EF (%) 74 5 27 9† 29
ata are presented as mean SD. *Treatment groups were statistically compared with 4 weeks
EF  ejection fraction; FS  fractional shortening; HR  heart rate; LV  left ventricle; LVD  left vThe uptake of CRIP in the infarct area was signifi-
antly higher at 2 weeks compared with that at 4 or 12
eeks after MI; the uptake almost completely resolved by
2 weeks in the infarct area (data not shown). The
ime-response curve of CRIP uptake in post-MI hearts
ay parallel the expression dynamics of v3, as observed
n hepatic stellate cells (22). Myofibroblasts evolve and
re activated by inflammatory cytokines elicited in the
rea following the insult. Collagen and other matrix
olecules are produced, and integrins are up-regulated to
ttach the cells to the matrix for survival and prolifera-
ion. The expression of 3 integrins is associated with
ngiogenesis in the peri-infarct zone and peaks around 7
ays after MI as part of the remodeling process. Subse-
uently, as inflammation resolves, collagen fibrils are
ross linked by transglutaminase activity, no more ligands
re available for v3 binding, and the cells disappear
hrough apoptosis or anoxis (22). Therefore, after 12
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tal Projection
h After Radiolabeled CRIP Administration
he unmanipulated animal (top row). On the other hand, intense anterior uptake
computed tomography (CT) fusion image. MI  myocardial infarction; SPECT 
ion
12 Weeks
4 Weeks
Captopril Captopril  Losartan*
5 4 4
405 63‡ 324 30 376 106
47 12† 38 16 31 13
0.6 0.06§ 0.5 0.07 0.5 0.06
† 0.51 0.08† 0.4 0.1 0.39 0.1
14 7† 29 9§ 24 12
34 14† 41 6 47 15
I. †p  0.05 versus normal control, ‡p  0.05 versus 2 weeks, §p  0.05 versus 4 weeks.
diameter (s  systolic, d  diastolic); MI myocardial infarction/left ventricle area 100%.
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ntegrins for CRIP to bind to; in other words, there is
brosis, but little fibrogenesis or myofibroblasts in mouse
nfarcts. However, since myofibroblasts have been re-
orted up to 20 years after MI in well-healed human
nfarcts (23), the binding characteristics of CRIP may be
ifferent in humans than in rodent hearts.
Unlike the infarcted zone, CRIP uptake in the remote
yocardium was higher at 12 weeks. It is well established
hat alterations in interstitial collagen can significantly
nfluence the size and shape of the cardiac chamber as well
s ventricular function and hence, ventricular remodeling
24). Excessive collagen deposition or pathologic fibrosis
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Figure 4 Ex Vivo Images of the Explanted Hearts in Control an
(A) Control heart with Cy5.5-RGD imaging peptide (CRIP) probe and 4-week post-m
other hand, intense CRIP uptake is seen in 2-week post-MI animal. The uptake in
after MI. (B) Quantitative technetium-CRIP uptake in the infarct (apex), peri-infarct
is highest in mice 2 weeks after MI, followed by 4 and 12 weeks after MI. On the
uptake from 2 to 12 weeks after MI. No uptake of scrambled peptide was seen in
presented as mean  standard error of the mean.ontributes to LV dysfunction and poor prognosis in MI catients by inducing myocardial stiffness, promoting devel-
pment of arrhythmias, and adversely affecting systolic
unction (25).
The myocardium contains an endogenous renin-angiotensin
ystem, and activation of the renin-angiotensin-aldosterone
xis results in cardiac fibroblast proliferation and fibrosis
26,27). This response is transduced by angiotensin recep-
ors, which are far more abundant on cardiac fibroblasts
han on myocytes (28). Angiotensin II acts through the
p-regulation of additional fibrogenic growth factors, which
ediate or augment the effects of angiotensin II, including
ransforming growth factor 1. Up-regulation of angioten-
in production, angiotensin II type 1 receptors, and in-
bled
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farct zone. Quantitative data confirmed the findings of ex vivo images. Data areram
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ntiangiotensin therapy may prevent adverse myocardial
emodeling. The uptake of Tc-CRIP was markedly reduced
y captopril alone and more so in combination with losar-
an. Although angiotensin II levels decrease initially with
ngiotensin-converting enzyme inhibitor therapy (30,31),
heir levels may rise gradually over time due to alternative
onversion pathways. Therefore, therapy with a combina-
ion of an angiotensin-converting enzyme inhibitor with an
ngiotensin receptor blocker acts synergistically and may
ave a benefit greater than that with either agent used alone.
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Figure 5 Radiolabeled CRIP Uptake After Captopril and Losarta
In 4-week post-myocardial infarction (MI) animals, captopril treatment alone and in
observed in gamma images of the explanted hearts (A). Quantitative technetium-la
peutic intervention in infarcted and nonsignificantly lower in noninfarcted areas (B)he present study demonstrates the relatively superior effect Af combination therapy in reducing fibrogenesis compared
ith captopril therapy alone. Although the OPTIMAAL
Optimal Therapy in Myocardial Infarction with the An-
iotensin II Antagonist Losartan) and the VALIANT
Valsartan in Acute Myocardial Infarction) studies did not
ubstantiate the concept of combination therapy in post-MI
atients (32,33), the Val-HeFT (Valsartan Heart Failure
rial) and CHARM (Candesartan in Heart Failure–
ssessment of Reduction in Mortality and Morbidity) studies
ave demonstrated the superior efficacy of combination therapy
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rognosis in patients with HF and the present study demon-
trates a decrease in collagen deposition after captopril with or
ithout losartan treatment, it is possible that the decrease in
ollagen deposition is a favorable phenomenon. Alternatively,
e hypothesize that the impact of antiangiotensin therapy on
he infarct zone may be relatively lower as compared with that
n the remote region, where all collagen formation may get
brogated. As such, evaluation of the impact of therapy at 12
eeks could have offered more information.
Since LV remodeling post-MI is the leading cause of HF
nd is a determinant of morbidity and mortality (3,36), it is
mportant to predict the likelihood of occurrence of cardiac
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Figure 6 Histopathological Characterization of Control and 4-W
Masson’s trichrome (A, D) and sirius red (B, E) staining, and sirius red staining w
(D to H) in a heart 4 weeks after myocardial infarction (MI). The remote area is fro
shows minimal fibrosis (A) and collagen deposition (B, C). On the other hand, the
gen deposition (E, F). Two areas from (F) are magnified to demonstrate collagen d
characterization with anti-alpha smooth muscle actin (ASMA) antibody (brown) of t
number of myofibroblasts over time.emodeling. It is possible to detect the occurrence of iollagen formation post-MI by measuring pro-collagen I
nd III in serum. The measurements of these markers have
een shown to provide independent information pertaining
o LV function (37,38) and survival (39,40) in patients with
F. However, these markers are not specific and may not be
f value in patients with other conditions associated with
ollagen formation, such as arthritis (41). The potential
alue of radiolabeled CRIP is its ability to noninvasively
ocalize at the site of interstitial alterations and collagen
ormation in the myocardium, and therefore may provide
nformation about the evolution of HF. Our pilot clinical
tudy with a radiolabeled RGD peptide in patients at 3
nd 8 weeks after MI has shown the feasibility of
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tion in the infarct center (G) and in the infarct border (H). Immunohistochemical
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APPENDIX
or a table on the tracer uptake in organs
nd blood, please see the online version of this article.
